Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 355

1.

Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies.

Friedberg JW, Neuberg D, Gribben JG, Mauch P, Anderson KC, Soiffer RJ, Takvorian T, Fisher DC, Schlossman R, Jallow H, Kuhlman C, Ritz J, Freedman AS.

Biol Blood Marrow Transplant. 1999;5(4):262-8.

2.

Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma.

Freedman AS, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Fisher DC, Schlossman R, Alyea EP, Takvorian T, Jallow H, Kuhlman C, Ritz J, Nadler LM, Gribben JG.

Blood. 1999 Nov 15;94(10):3325-33.

3.

Autologous bone marrow transplantation for marginal zone non-Hodgkin's lymphoma.

Brown JR, Gaudet G, Friedberg JW, Neuberg D, Mauch P, Kutok JL, Takvorian T, Fisher DC, Gribben JG, Kim H, Nadler LM, Freedman AS.

Leuk Lymphoma. 2004 Feb;45(2):315-20.

PMID:
15101717
4.

Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma.

Verdonck LF, Dekker AW, Lokhorst HM, Petersen EJ, Nieuwenhuis HK.

Blood. 1997 Nov 15;90(10):4201-5.

6.

High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission.

Freedman AS, Gribben JG, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Pandite L, Robertson MJ, Kroon M, Ritz J, Nadler LM.

Blood. 1996 Oct 1;88(7):2780-6.

7.

Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma.

Berglund A, Enblad G, Carlson K, Glimelius B, Hagberg H.

Eur J Haematol. 2000 Jul;65(1):17-22.

PMID:
10914935
8.

The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma.

Friedberg JW, Neuberg D, Monson E, Jallow H, Nadler LM, Freedman AS.

Biol Blood Marrow Transplant. 2001;7(8):446-53.

PMID:
11569890
9.

Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.

Aksentijevich I, Jones RJ, Ambinder RF, Garrett-Mayer E, Flinn IW.

Biol Blood Marrow Transplant. 2006 Sep;12(9):965-72.

10.

High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience.

Cao TM, Horning S, Negrin RS, Hu WW, Johnston LJ, Taylor TL, Shizuru JA, Hoppe RT, Brown BW, Blume KG, Stockerl-Goldstein KE.

Biol Blood Marrow Transplant. 2001;7(5):294-301.

PMID:
11400952
11.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Review.

PMID:
12042984
12.

Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.

Colombat P, Cornillet P, Deconinck E, Tourani JM, Gardembas M, Delain M, Abgrall JF, Kootz C, Milpied N.

Bone Marrow Transplant. 2000 Nov;26(9):971-7.

13.

Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse.

Soiffer RJ, Roy DC, Gonin R, Murray C, Anderson KC, Freedman AS, Rabinowe SN, Robertson MJ, Spector N, Pesek K, et al.

Bone Marrow Transplant. 1993 Sep;12(3):243-51.

PMID:
8241984
14.

Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.

de Lima M, van Besien KW, Giralt SA, Khouri IF, Mehra R, Andersson BS, Przepiorka D, Gajewski JL, Korbling M, Champlin RE.

Bone Marrow Transplant. 1997 Jan;19(2):121-7.

15.
16.

Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma.

Chen CI, Crump M, Tsang R, Stewart AK, Keating A.

Br J Haematol. 2001 Apr;113(1):202-8.

PMID:
11328303
17.

Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging.

Uckun FM, Kersey JH, Vallera DA, Ledbetter JA, Weisdorf D, Myers DE, Haake R, Ramsay NK.

Blood. 1990 Nov 1;76(9):1723-33.

18.

High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission.

Nademanee A, Molina A, Fung H, Stein A, Parker P, Planas I, O'Donnell MR, Snyder DS, Kashyap A, Spielberger R, Bhatia R, Krishnan A, Sniecinski I, Vora N, Slovak M, Dagis A, Niland JC, Forman SJ.

Biol Blood Marrow Transplant. 1999;5(5):292-8.

19.

High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot study.

Nademanee A, Schmidt GM, O'Donnell MR, Snyder DS, Parker PA, Stein A, Smith E, Lipsett JA, Sniecinski I, Margolin K, et al.

Blood. 1992 Sep 1;80(5):1130-4.

20.

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial.

Horning SJ, Negrin RS, Hoppe RT, Rosenberg SA, Chao NJ, Long GD, Brown BW, Blume KG.

Blood. 2001 Jan 15;97(2):404-9.

Supplemental Content

Support Center